More NewsRead More
SCYNEXIS Announces Launch of Public Offering of Common Stock
April 20, 2015
SCYNEXIS, Inc. Reports Full Year 2014 Financial Results
March 30, 2015
SCYNEXIS, Inc. Appoints Steven C. Gilman, Ph.D., to Board of Directors
February 27, 2015
SCYNEXIS Names Marco Taglietti, M.D., Chief Executive Officer
February 06, 2015
SCYNEXIS, Inc. Receives FDA Fast Track Designation for Oral Formulation of SCY-078 for the Treatment of Patients With Invasive Fungal Infections
January 09, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here